Abolfazl Avan

Has grant

Adjunct Research Professor

Western University
Country flagCanada

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Abolfazl Avan is an Adjunct Research Professor at Western University in Canada. His research areas focus on dementia, stroke, and the global health burden, as evidenced by his recent publications on trends in dementia incidence and health system performance. Additionally, he investigates the role of key factors like zinc in treating neurological conditions and has contributed to the understanding of brain health and its implications for overall well-being.

Recent Grants

Grant: Close

Fellowship Award for the Alzheimer’s Association International Conference® 2022

Open Date: 2022-01-01

Close Date: 2022-01-01

Grant: Close

Fellowship Award for the Alzheimer’s Association International Conference 2021

Open Date: 2021-01-01

Close Date: 2021-01-01

Grant: Close

MDS Travel Grants

Open Date: 2013-06-01

Close Date: 2013-07-01

Grant: Close

Free Copper Prize

Open Date: 2012-01-01

Close Date: 2012-01-01

Grant: Close

Scientific Honour

Open Date: 2009-04-01

Close Date: 2009-05-01

Articles (10)

Background and purpose The declining incidence of stroke, ischaemic heart disease (IHD) and dementia (the ‘triple threat’) in Norway encourages further investigation. The risks and trends of the three conditions were analysed using data from the Global Burden of Disease study. Methods Global Burden of Disease 2019 estimations were used for age‐, sex‐ and risk‐factor‐specific incidence and prevalence of the ‘triple threat’, their risk‐factor‐attributed deaths and disability combined, their age‐standardized rates per 100,000 population in 2019 and their changes during 1990–2019. Data are presented as means and 95% uncertainty intervals. Results In 2019, 71.1 thousand Norwegians were living with dementia, 157.2 thousand with IHD and 95.2 thousand with stroke. In 2019, there were 9.9 thousand (8.5 to 11.3) new cases of dementia (35.0% increase since 1990), 17.0 thousand (14.6 to 19.6) with IHD (3.6% decrease) and 8.0 thousand (7.0 to 9.1) with stroke (12.9% decrease) in Norway. During 1990–2019, their age‐standardized incidence rates decreased significantly—dementia by −5.4% (−8.4% to −3.2%), IHD by −30.0% (−31.4% to −28.6%) and stroke by −35.3% (−38.3% to −32.2%). There were significant declines in the attributable risks to both environmental and behavioural factors in Norway, but contradictory trends for metabolic risk factors during 1990–2019. Conclusions The risk of the ‘triple threat’ conditions is declining in Norway, despite the increased prevalence. This offers the opportunity to find out why and how and to accelerate their joint prevention through new approaches and the promotion of the National Brain Health Strategy.

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Anna Czlonkowska

Professor

Institute of Psychiatry and Neurology

POLAND
View details

Matthias Endres

Prof. Dr. med.

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin

GERMANY
View details

José M Ferro

University of Lisbon

PORTUGAL
View details

Parnaz Daneshpajouhnejad

Johns Hopkins University School of Medicine

UNITED STATES
View details

ali yadollahpour

University of Sheffield

UNITED KINGDOM
View details

Lauren E. Cipriano

Associate Professor

Western University

CANADA
View details

Stefano L. Sensi

-

ITALY
View details

Vladimir Hachinski

-

CANADA
View details

Susan Gaskin

Professor

McGill University

CANADA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.